Riskpilot← Back to searchSign inGet full accessME Läkare AB
ABActiveOrg 5591142178Pukslagargatan 2 BGeneral medical practice activities · NACE 8621Est. 20171 employees
Revenue 2024
SEK 176K
+4% vs 2023
EBITDA margin
12.1%
+166% vs 2023
Equity ratio
-224.4%
Financial strength
Net profit 2024
SEK 19K
+158% vs 2023
| Revenue | SEK 176K | +4% |
| EBITDA | SEK 21K | +166% |
| Net profit | SEK 19K | +158% |
| Total assets | SEK 53K | +147% |
| Equity | SEK -118K | +14% |
| Employees | 1 | — |
Legal name
ME Läkare AB
Org number
5591142178
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
1 juni 2017
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Konsultverksamhet inom sjukvård. Båda ägarna är legitimerade läkare och avser att hyra ut våra tjänster till exempelvis bemanningsföretag samt privata aktörer inom vården .
Address
Pukslagargatan 2 B
Email
ivan_ernudd@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 156 | 182 | 165 | 169 | 176 |
| Staff expenses | — | — | −73 | −72 | −72 |
| EBITDA | −26 | −12 | −38 | −32 | 21 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | −26 | −12 | −38 | −32 | 21 |
| Net financials | −1 | — | −0 | −1 | −1 |
| Profit before tax | −26 | −13 | −39 | −33 | 21 |
| Tax | −0 | −0 | — | — | −2 |
| Net profit | −26 | −13 | −39 | −33 | 19 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 28 | 71 | 41 | 21 | 53 |
| Equity | −53 | −66 | −104 | −137 | −118 |
| Long-term debt | 0 | 52 | 94 | 112 | 112 |
| Short-term debt | 81 | 85 | 51 | 47 | 59 |
| Total debt | 81 | 137 | 145 | 159 | 171 |
EBITDA margin
12.1%
This company
15.8%
Market median
-23% vs market
20202024
Equity ratio
-224.4%
This company
38.2%
Market median
-687% vs market
20202024
Return on equity
1907800.0%
This company
18.4%
Market median
+10368378% vs market
20202024
Net profit margin
10.9%
This company
8.1%
Market median
+35% vs market
20202024
Asset turnover
3.33×
This company
1.12×
Market median
+197% vs market
20202024
Debt / equity
1.45×
This company
0.62×
Market median
-134% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ME Läkare AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ivan Alexander Ernudd | Board of Directors | 0 companies |
| Ängla Anna Erica Mantel | Deputy Board Member | 0 companies |